फॉरेक्स के समाचार

More Pain Predicted For South Korea Stock Market

More Pain Predicted For South Korea Stock Market

The South Korea stock market has finished lower in three straight sessions, dropping more than 40 points or 1.7 percent along the way. The KOSPI now rests just above the 2,580-point plateau and it may take further damage again on Thursday.
RTTNews | 783 दिनों पहले
New Zealand Trade Data Due On Thursday

New Zealand Trade Data Due On Thursday

New Zealand will on Thursday release May figures for imports, exports and trade balance, highlighting a light day for Asia-Pacific economic activity.
RTTNews | 783 दिनों पहले
TSX Ends Lower For 4th Straight Session

TSX Ends Lower For 4th Straight Session

The Canadian market ended weak on Wednesday, weighed down by losses in technology, real estate, consumer staples and consumer discretionary sectors.
RTTNews | 783 दिनों पहले
Dollar Loses Ground Against Major Rivals Despite Powell's Hawkish Comments

Dollar Loses Ground Against Major Rivals Despite Powell's Hawkish Comments

The U.S. dollar shed ground against its major counterparts on Wednesday despite Federal Reserve Chair Jerome Powell, who testified before the House Financial Services Committee today, reiterating that the central bank will likely continue raising rates to contain inflation.
RTTNews | 783 दिनों पहले
Swiss Market Fails To Hold Early Gains, Ends Modestly Lower

Swiss Market Fails To Hold Early Gains, Ends Modestly Lower

After a weak start and a subsequent recovery that resulted in a positive spell till about an hour past noon on Wednesday, the Switzerland market fell into negative territory and eventually ended the day's session modestly lower.
RTTNews | 783 दिनों पहले
more news
Aldeyra Therapeutics Gets CRL From FDA For NDA Of ADX-2191 To Treat Primary Vitreoretinal Lymphoma

Aldeyra Therapeutics Gets CRL From FDA For NDA Of ADX-2191 To Treat Primary Vitreoretinal Lymphoma

Biotechnology company Aldeyra Therapeutics, Inc. (ALDX) announced Wednesday the receipt of a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for the 505(b)(2) New Drug Application (NDA) of ADX-2191 (methotrexate for injection, USP), an investigational drug candidate, for the treatment of primary vitreoretinal lymphoma (PVRL).
RTTNews | 783 दिनों पहले
Bay Street Likely To See Subdued Start

Bay Street Likely To See Subdued Start

Canadian shares are likely to open on a somewhat subdued note on Wednesday, amid a lack of positive triggers.
RTTNews | 783 दिनों पहले

Stay up to date!

Add न्यूज to your browser

Extension Picture